Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Proto

Showing results (511-520 of 595) with videos related to

Pageof 60
Sort By:
Tumori|September 23, 2024
Is tumour sequencing effective for the identification of germline <i>BRCA1/2</i> pathogenic variant carriers?Jacopo Azzollini, Iolanda Capone, Matteo Duca, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2019
Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancerLucio Crinò, Giuseppe Bronte, Paolo Bidoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based ChemotherapyRoberto Ferrara, Marie Naigeon, Edouard Auclin, et al.
Cancers|December 11, 2019
EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation CohortArsela Prelaj, Roberto Ferrara, Sara Elena Rebuzzi, et al.
Nature Neuroscience|December 19, 2022
Microglia ferroptosis is regulated by SEC24B and contributes to neurodegenerationSean K Ryan, Matija Zelic, Yingnan Han, et al.
JCO Precision Oncology|June 11, 2025
Real-World Outcomes of Molecular Tumor Board Treatment RecommendationsFederico Nichetti, Marta Brambilla, Matteo Duca, et al.
The Oncologist|October 5, 2023
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort StudyFederica Pecci, Luca Cantini, Valeria Cognigni, et al.
Clinical Lung Cancer|August 10, 2022
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung CancerGiulia Galli, Paola Antonia Corsetto, Claudia Proto, et al.
Communications Biology|August 2, 2024
Glucosylceramide synthase modulation ameliorates murine renal pathologies and promotes macrophage effector function in vitroAgnes Cheong, Florin Craciun, Hervé Husson, et al.
Clinical Lung Cancer|August 2, 2021
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon HistologySara Manglaviti, Marta Brambilla, Diego Signorelli, et al.
Pageof 60

Showing results (511-520 of 595) with videos related to

Sort By:
Pageof 60
Tumori|September 23, 2024
Is tumour sequencing effective for the identification of germline <i>BRCA1/2</i> pathogenic variant carriers?Jacopo Azzollini, Iolanda Capone, Matteo Duca, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2019
Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancerLucio Crinò, Giuseppe Bronte, Paolo Bidoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based ChemotherapyRoberto Ferrara, Marie Naigeon, Edouard Auclin, et al.
Cancers|December 11, 2019
EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation CohortArsela Prelaj, Roberto Ferrara, Sara Elena Rebuzzi, et al.
Nature Neuroscience|December 19, 2022
Microglia ferroptosis is regulated by SEC24B and contributes to neurodegenerationSean K Ryan, Matija Zelic, Yingnan Han, et al.
JCO Precision Oncology|June 11, 2025
Real-World Outcomes of Molecular Tumor Board Treatment RecommendationsFederico Nichetti, Marta Brambilla, Matteo Duca, et al.
The Oncologist|October 5, 2023
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort StudyFederica Pecci, Luca Cantini, Valeria Cognigni, et al.
Clinical Lung Cancer|August 10, 2022
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung CancerGiulia Galli, Paola Antonia Corsetto, Claudia Proto, et al.
Communications Biology|August 2, 2024
Glucosylceramide synthase modulation ameliorates murine renal pathologies and promotes macrophage effector function in vitroAgnes Cheong, Florin Craciun, Hervé Husson, et al.
Clinical Lung Cancer|August 2, 2021
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon HistologySara Manglaviti, Marta Brambilla, Diego Signorelli, et al.
Pageof 60